Lymphocyte subpopulations in the neonate: a subset of HNK-1-, OKT3-, OKT8+ lymphocytes displays natural killer activity. 1984

A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio

It has been recently reported that cord blood lymphocytes (CBL) contain a subpopulation of OKT8+, sheep erythrocyte-rosetting negative (E-) cells not detectable in adult peripheral blood lymphocytes (a-PBL). The present studies were undertaken to characterize this subset of lymphocytes functionally and phenotypically. OKT8+ cells were purified from E-depleted CBL by negative selection on nylon-wool columns as well as by positive selection on plates coated with rabbit antibody to murine IgG (panning). The purified CBL displayed natural killer (NK) activity against K562 erythroleukemic cells. Although most of these CBL were large granular lymphocytes, they lacked typical NK markers such as HNK-1 and OKM1 surface antigens. Most OKT8+, OKT3- cells were also OKT10+, Ia+ and had the receptor for peanut agglutinin. These CBL may represent a stage along the differentiation pathway leading to mature NK or T cells.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
January 1986, Thymus,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
August 1993, British journal of anaesthesia,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
March 1987, Clinical and experimental immunology,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
September 1984, Scandinavian journal of immunology,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
November 1982, Cellular immunology,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
October 1981, Clinical immunology and immunopathology,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
April 1991, Acta endocrinologica,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
July 1986, The Journal of experimental medicine,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
April 1986, Immunological investigations,
A Vitiello, and R Maccario, and D Montagna, and F A Porta, and C M Alberini, and G Mingrat, and G C Astaldi-Ricotti, and L Nespoli, and A G Ugazio
October 1988, The Journal of investigative dermatology,
Copied contents to your clipboard!